AVR anteris technologies global corp.

$66.32 price target - Evolution Capital initiation of coverage, page-107

  1. 252 Posts.
    lightbulb Created with Sketch. 45
    Aside from any additional support for the FDA trial, the Georgia study will provide results that will be able to be published in a peer reviewed journal.......and a positive outcome cant hurt the acceptance of the product - either by the FDA or clinicians.........

    just my 2 cents worth.....
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$5.98
Change
-0.140(2.29%)
Mkt cap ! $92.99M
Open High Low Value Volume
$6.01 $6.08 $5.95 $28.28K 4.712K

Buyers (Bids)

No. Vol. Price($)
1 500 $5.95
 

Sellers (Offers)

Price($) Vol. No.
$6.07 2710 2
View Market Depth
Last trade - 13.16pm 26/06/2025 (20 minute delay) ?
AVR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.